Given a disease prevalence of 10% and an antibody test false‑positive rate of 30%, which metric should be calculated to determine the probability that a person with a positive test truly has the infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Positive Predictive Value

You should calculate the positive predictive value (PPV) to determine the likelihood that you actually have this virus given your positive test result. 1

Why PPV is the Correct Answer

When you receive a positive test result, you need to know the posterior probability—the actual chance you have the disease after testing positive. This is precisely what PPV tells you. 1

PPV is defined as the probability that a person has the disease given a positive test result. 1 In your scenario with 10% prevalence and 30% false-positive rate (meaning 70% specificity), the PPV will tell you what proportion of positive test results are true positives versus false positives.

Understanding the Clinical Context

The ESCMID guidelines explicitly state: "The posterior probability of a positive test result (PPV) is the probability that a person has the disease, given the positive result." 1

With a relatively low prevalence of 10% and a concerning false-positive rate of 30%, your PPV will be substantially reduced. The guidelines demonstrate that "in a tested population with a low prior probability for the disease, a positive test result will only be proof of the disease if the test is free of false positives (specificity of 100%). Otherwise the posterior probability (PPV) will be only 50%, even in the case of a high sensitivity." 1

Why Not the Other Options?

  • Negative predictive value (NPV): This tells you the probability of not having the disease when you test negative—irrelevant since you tested positive
  • Sensitivity: This is the probability of testing positive if you have the disease—but you need the reverse calculation
  • Specificity: This is the probability of testing negative if you don't have the disease—again, the wrong direction
  • Odds ratio: This is a measure of association used in epidemiological studies, not for individual test interpretation

The Mathematical Relationship

PPV depends on three factors:

  • Prevalence (your pre-test probability): 10%
  • Sensitivity (not provided, but needed)
  • Specificity: 70% (derived from 30% false-positive rate)

The formula incorporates all three to give you the actual probability of infection given your positive result. 1

Clinical Implications

A low PPV means many positive test results are false positives, leading to unnecessary treatment and anxiety. 1 The ESCMID guidelines emphasize that at low prevalences (5-10%), even tests with high specificity can have unacceptably low PPVs, and they recommend a two-step testing approach with confirmatory testing for positive results. 1

In your case, with 10% prevalence and 70% specificity, you should expect a moderate PPV—meaning a substantial proportion of positive results will be false positives, making confirmatory testing advisable.

Related Questions

After two unprotected insertive encounters with women, a negative HIV RNA test performed 20 days post‑exposure, no further exposures, and no use of pre‑exposure prophylaxis, what is the likelihood that a fourth‑generation HIV antigen/antibody test at 120 days will become positive, and can I be confident the result will remain negative?
After having unprotected insertive intercourse with two women on [DATE] and [DATE] and a negative HIV RNA test at 20 days post‑exposure, what is the probability that a fourth‑generation HIV antigen/antibody test performed at 125 days post‑exposure (with no further exposures and no PrEP) will be positive?
I had an HIV RNA test performed 20 days after a possible exposure, which was negative and has reported 100% sensitivity and 99.83% specificity; I have had no further exposures, am not on pre‑exposure prophylaxis, and have a female partner—do I need any additional HIV testing before my scheduled fourth‑generation antigen/antibody test in September?
What are the causes of atypical antibody responses?
What do the dilution ratios 2:10 and 1:40 indicate in antibody titer testing?
How is duloxetine used to treat stress urinary incontinence in women, including recommended dosing, contraindications, and monitoring?
Is bupropion/naloxone safe to use with phosphodiesterase‑5 inhibitors (PDE5 inhibitors) such as sildenafil, tadalafil, or vardenafil?
Can prostate-specific antigen (PSA) be elevated during a shingles (herpes zoster) infection?
What are the mechanisms of action of sodium‑glucose co‑transporter‑2 (SGLT2) inhibitors?
Does apple cider vinegar affect the absorption of selective serotonin reuptake inhibitors (SSRIs) such as sertraline, fluoxetine, escitalopram, or citalopram?
What is the urgent evaluation and management approach for an adult with rapid-onset ascending paralysis and no prior neurologic disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.